Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Galapagos Compound Unit Goes To Evotec
by Rick Mullin
June 6, 2011
| A version of this story appeared in
Volume 89, Issue 23
Evotec has spent approximately $18 million to acquire Galapagos’ Compound Focus compound management unit. Located in South San Francisco, the business specializes in acquiring, formatting, storing, and shipping compound libraries for drug research labs (C&EN, April 11, page 24). It had sales of about $11 million last year. Evotec CEO Werner Lanthaler says the acquisition will strengthen his company’s existing compound management services and enhance its compound-screening platform. Galapagos says it will concentrate on drug discovery services through its BioFocus and Argenta businesses.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter